Fountain Therapeutics, Inc. — Form D/A
Fountain Therapeutics, Inc. of South San Francisco, CA, a company, filed a Form D amendment with the SEC on 2018-09-18. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-09-18
- Form: D/A
- Accession: 0001739815-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 2
- Date of first sale: 2018-05-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-311831
Issuer
- Name: Fountain Therapeutics, Inc.
- CIK: 0001739815
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 681 Gateway Blvd., South San Francisco, CA, 94080
- Phone: 650-856-1971
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Thomas A Rando | Director | Stanford, CA |
| Thomas A Rando | Executive Officer | Stanford, CA |
| Thomas A Rando | Promoter | Stanford, CA |
| Alex Morgan | Director | Austin, TX |
| William Greene | Director | South San Francisco, CA |
| William Greene | Executive Officer | South San Francisco, CA |
| Thomas Rando | Director | South San Francisco, CA |
| Thomas Rando | Executive Officer | South San Francisco, CA |
| Ashish Khanna | Director | South San Francisco, CA |
| John Dimos | Director | San Francisco, CA |
| John Dimos | Executive Officer | San Francisco, CA |
Other filings by this issuer (3)
More